Antihypertensive and monoamine oxidase inhibitory activity of 3-amino-2-oxazolidinone (3AO) and its condensation product with 2-substituted-3-formyl-4-oxo-(4H) pyrido(1,2-a)pyrimidines.
D000588:Amines / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000201:enzymology / Q000378:metabolism; D001923:Brain Chemistry; D002415:Cats; D004285:Dogs; D004298:Dopamine / Q000032:analysis; D004357:Drug Synergism; D005561:Formates / Q000494:pharmacology; D007659:Ketones / Q000494:pharmacology; D008099:Liver / Q000201:enzymology; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism; D010080:Oxazoles / Q000494:pharmacology*; D011335:Proadifen / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology*; D011744:Pyrimidinones / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000032:analysis; D014191:Tranylcypromine / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology
D000588:Amines; D000959:Antihypertensive Agents; D005561:Formates; D007659:Ketones; D008996:Monoamine Oxidase Inhibitors; D010080:Oxazoles; D011725:Pyridines; D011744:Pyrimidinones; D012701:Serotonin; D014191:Tranylcypromine; D011335:Proadifen; D008995:Monoamine Oxidase; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine